STAT | Reporting from the frontiers of health and medicine

Skip to Main Content

Experience STAT's journalism live at an upcoming STAT Summit

Experience STAT's journalism live at an upcoming STAT Summit

August 21, 2026

A cure for HIV would be a triumph. But it shouldn’t harm survivors
August 21, 2026

Lil Nas X’s bipolar diagnosis and the paradox of treatment
August 20, 2026

STAT Plus: How a Trump loyalist got the FDA nomination
August 20, 2026

STAT Plus: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection
August 20, 2026

STAT Plus: One of the most consequential years for cancer treatment, ever
August 20, 2026

The global health aid architecture is collapsing. The faith economy isn’t

Test your knowledge with our now weekday mini crossword

Play the STAT Mini

Out of Pocket, Out of Reach: Why has employer-based health insurance become so unaffordable?

Read the series

She grew up unvaccinated. Now she’s a leading voice for science — and empathy

Immunologist Liz Marnik urges patience with people like her mother who feared shots

Exclusive August 18, 2026

STAT Plus: A pill that mimics exercise? Early results on drug designed to maintain both weight loss and muscle mass

Out of Pocket, Out of Reach August 18, 2026

How health care costs are undermining America’s public-sector employers

Health August 21, 2026

Focal therapy for localized prostate cancer has divided physicians. Will new data change minds?

Health August 21, 2026

STAT Plus: HHS document offers new clues to Kennedy’s vaccine plans

Sponsored

Advertisement

Sign up for Newsletters

STAT+

Your go-to source for the world of life sciences, medicine, and biopharma. Subscribe now.

Cancel anytime.

STAT Plus: HHS document offers new clues to Kennedy’s vaccine plans

STAT Plus: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial

STAT Plus: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection

STAT Plus: One of the most consequential years for cancer treatment, ever

STAT Plus: How Trump loyalist Heidi Overton became the president’s pick to run the FDA

All STAT+ Stories

All Events

More From STAT

More From STAT

More From STAT

STAT offers a variety of in-person and virtual events throughout the year.

All Events

Biosimilars: Have We Reached an Inflection Point?

Virtual

A conversation on the future of biosimilars as competition grows and policy continues to evolve.

2026 STAT Summit

Boston, MA

All Events

All Trackers

More From STAT

More From STAT

More From STAT

We create tools to help you understand and track complex areas of development.

All Trackers

Obesity Drug Tracker

Here are the dozens of weight loss drugs in development to catch a booming market.

CRISPR Tracker

Follow the latest developments in genome editing.

Generative AI Tracker

A guide to the health systems and companies driving adoption.

Breakthrough Device Tracker

An authoritative database of FDA’s fast-tracked medical devices.

All Reports

More From STAT

More From STAT

More From STAT

STAT Reports blend data insights with qualitative observations on pivotal life sciences topics.

All Reports

Chaotic and politicized: Inside the FDA under Trump

$49

Explore how turmoil and political pressure have destabilized the agency with mass layoffs, rapid staff departures, and a revolving door of leadership.

All Podcasts

More From STAT

More From STAT

More From STAT

From policy to practice: STAT's podcasts decode health care complexities.

All Podcasts

The Readout LOUD

Our weekly biotech podcast digs deep into industry goings-on.

First Opinion Podcast

A weekly interview show featuring the most interesting people and ideas in medicine.

Color Code

Enjoy the archives of Color Code, our podcast on racial inequities in American health care.

More From STAT

View upcoming events Play the STAT Mini Crossword Explore trackers Download our latest Report Listen to STAT podcasts

More Stories

First Opinion August 21, 2026

A cure for HIV would be a triumph. But it shouldn’t harm survivors

First Opinion August 21, 2026

Lil Nas X’s bipolar diagnosis and the paradox of treatment

D.C. Diagnosis August 20, 2026

STAT Plus: How a Trump loyalist got the FDA nomination

Adam's Biotech Scorecard August 20, 2026

STAT Plus: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection

Adam's Biotech Scorecard August 20, 2026

STAT Plus: One of the most consequential years for cancer treatment, ever

First Opinion August 20, 2026

The global health aid architecture is collapsing. The faith economy isn’t

Health August 20, 2026

Can reclassifying muscle dysmorphia unlock better care for boys and men?

Health August 20, 2026

Reduce protein to increase longevity? Nutrition experts say that’s a bad idea

First Opinion August 20, 2026

Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study

Health tech August 20, 2026

STAT Plus: How health systems are embracing chatbots to query and summarize patient records

Politics August 19, 2026

STAT Plus: How Trump loyalist Heidi Overton became the president’s pick to run the FDA

Politics August 19, 2026

STAT Plus: New CDC director tells staff she is prepared to speak ‘truth to power’

Pharmalot August 21, 2026

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot August 21, 2026

STAT Plus: Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and more

The Readout August 21, 2026

STAT Plus: Are cancer patients getting too much drug?

The Readout August 20, 2026

STAT Plus: FDA approves Ultragenyx gene therapy

Pharmalot August 20, 2026

STAT Plus: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more

The Readout August 19, 2026

STAT Plus: Experts scrutinize Huidagene’s disclosures after patient death

First Opinion August 21, 2026

A cure for HIV would be a triumph. But it shouldn’t harm survivors

First Opinion August 21, 2026

Lil Nas X’s bipolar diagnosis and the paradox of treatment

Adam's Biotech Scorecard August 20, 2026

STAT Plus: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection

Adam's Biotech Scorecard August 20, 2026

STAT Plus: One of the most consequential years for cancer treatment, ever

First Opinion August 20, 2026

The global health aid architecture is collapsing. The faith economy isn’t

First Opinion August 20, 2026

Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study

Newsletters

Mon - Fri

Your daily dose of news in health and science

Our Picks

Our Picks

STAT’s selection of must-read stories and investigations

How America’s employer-based health care system continues to crumble in slow motion

As Maui recovers from devastating fires, a study offers vision for new rural health model

By Angus Chen and Crystal Milner

THC drinks are sold beside sodas, iced tea, and even chocolate milk, often in violation of state laws

STAT Plus: Telemedicine company touted by Novo Nordisk stressed profits over patient safety, ex-workers say

My husband’s suicide shows there’s something very wrong with the U.S. insurance industry

By Joy Evers

STAT Plus: I’m a cardiologist. I’m not sure the new cholesterol drug enlicitide is a game-changer

By Vishal Khetpal

12 ideas for tackling the U.S. alcohol epidemic

By Isabella Cueto and Lev Facher

STAT Plus: Under a new leader, the FDA’s biologics center moves to steady itself after stormy chapter

By Lizzy Lawrence

STAT Plus: In wake of boy’s death, gene editing experts dissect Huidagene’s decisions

Biotech August 19, 2026

STAT Plus: In wake of boy’s death, gene editing experts dissect Huidagene’s decisions

Biotech August 18, 2026

STAT Plus: Amylyx endocrine drug succeeds in pivotal study

Biotech August 17, 2026

STAT Plus: Eyepoint study results for vision treatment disappoint, but company still sees promise

STAT Plus: Pharmalittle: We’re reading about an FDA commish nominee, mRNA cancer vaccine results, and more

Pharmalot August 19, 2026

STAT Plus: Pharmalittle: We’re reading about an FDA commish nominee, mRNA cancer vaccine results, and more

Pharma August 18, 2026

STAT Plus: Trump expected to pick White House adviser Heidi Overton to lead FDA

Pharmalot August 18, 2026

STAT Plus: Pharmalittle: We’re reading about a setback for Eyepoint, a win for Amylyx, and more

STAT Plus: American Cancer Society cancels alcohol industry fundraiser

Health August 19, 2026

STAT Plus: American Cancer Society cancels alcohol industry fundraiser

Health August 19, 2026

Accrediting body considers changes to racism curriculum standards for public health schools

Health August 19, 2026

Physician group sues Trump administration over dietary guidelines process

Trump administration sued over visa time limit that would affect grad students, postdocs

Politics August 18, 2026

Trump administration sued over visa time limit that would affect grad students, postdocs

Politics August 17, 2026

STAT Plus: Kennedy’s split-screen week: Talk of vaccines in D.C., fraud and addiction out West

Politics August 6, 2026

Senate committee votes along party lines to hold Fauci in contempt of Congress

Video

What happens on ‘MAHA Monday’?

What does content creation do to mental health?

BIO 2026: AI, federal policy impacts, and general vibes

What’s next for GLP-1 weight loss drugs?

STAT Plus: What Medicare incentives for AI-based devices mean for tech companies — and hospitals

Health tech August 13, 2026

STAT Plus: What Medicare incentives for AI-based devices mean for tech companies — and hospitals

Health tech August 13, 2026

STAT Plus: What patients actually think about ‘minimally invasive’ brain implants

Health tech August 11, 2026

STAT Plus: Nurses seek a seat at the table as they fight expanding clinical AI

IRBs have a problem. Can North Star’s nonprofit model save it?

In the Lab August 11, 2026

IRBs have a problem. Can North Star’s nonprofit model save it?

In the Lab August 5, 2026

STAT Plus: Could poop pills be the next treatment for food allergies?

In the Lab July 29, 2026

NSF testing new Ph.D. model giving trainees academic and industry experience

STAT Plus: Leaders of Mass General, Dana-Farber among hospital execs who got big raises in 2024

Hospitals August 18, 2026

STAT Plus: Leaders of Mass General, Dana-Farber among hospital execs who got big raises in 2024

Hospitals July 8, 2026

STAT Plus: Mass General Brigham, nurses called to talk at State House amid biggest nursing strike in Mass.

Hospitals June 24, 2026

Judge temporarily blocks subpoenas in criminal probe of transgender care at New York hospitals

STAT Plus: More workers hate their jobs, but keep them for the health insurance

Insurance July 22, 2026

STAT Plus: More workers hate their jobs, but keep them for the health insurance

Insurance July 16, 2026

STAT Plus: Despite earnings celebration, UnitedHealth signals more financial pain for employers

Insurance July 15, 2026

STAT Plus: Elevance plots a Medicaid retreat as costs remain high

Podcasts

Capricor’s data clash and a fugitive in the C-suite

Whistleblower takes on health insurance and FDA commissioner candidates

The mysterious case of Eli Lilly’s obesity drug

How STAT decided to keep ‘health care’ as two words